A Cancer clinical trial involves the healthy people and cancer patients to test safety and efficacy of newly developed cancer drugs. Clinical trials are conducted for new effective medications. Clinical trials are conducted at different cancer hospitals. These studies help in diagnosing and treatment of cancer. A cancer clinical trial can also be said to be as a cancer clinical study.

The Journal is successfully running in the 4^th Volume which covers a wide variety of specialties including Cancer Surgery, Ovarian cancer, hepatitis infection, reaching out to analytical scientists worldwide. The Journal emphasizes high-level research and education. Original research articles, reviews, short communications, and letters to the editors in the fields of clinical trials are welcome. Every effort is made to have a speedy and critical peer-review process.

OMICS Group International is a leading Open Access publisher that publishes more than 700 leading-edge peer reviewed Open Access Journals and organizes over 1000 International Conferences globally with the support of nearly 1000 International Societies. OMICS International journals cater to over 3 million readers with the support of 50000 eminent personalities as editorial board members.

Prospective academicians and scientists are encouraged to utilize this opportunity to get their articles reviewed, processed and published at relatively faster pace and at lower charges. The journal invites different types of articles including original research article, review articles, short note communications, case reports, Editorials, letters to the Editors and expert opinions & commentaries from different regions for publication.

Manuscripts can be uploaded online at Editorial Tracking System (https://www.scholarscentral.org/submissions/cancer-clinical-trials.html) or forwarded to the Editorial Office   cancer@peerjournal.org

Media Contact:

Rebecca J
Assistant Editorial Manager
Journal of Cancer Clinical Trials
Whatsapp No:  +1-504-608-2390
Email:  cancer@eclinicalsci.com